Follow @keithspeights
Recent articles
Better Cannabis Stock: Charlotte's Web vs. KushCo Holdings
Both of these beaten-down cannabis stocks should have great long-term prospects.
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
And why it’s a potential problem for biotech investors.
The Most Important Stock to Own Over the Next Decade
Several trends will shape this decade. And there's one stock that should benefit from all of them.
3 Growth Stocks That Should Help You Retire Rich
All three stand to benefit from major long-term growth trends.
3 Dividend Stocks That Are Must-Haves for Your Retirement Portfolio
Strong dividends. Solid businesses. Retirees should love these three stocks.
3 Cancer Treatment Stocks to Buy Right Now
It's not just their cancer treatments that make these stocks attractive.
Better Buy: GlaxoSmithKline vs. Eli Lilly
These two big drugmakers are in very different positions right now. And one is the clear choice for long-term investors.
3 Biotech Stocks That Soared This Week: Are They Buys?
Can these high-flying biotech stocks keep up their sizzling momentum?
SEC Reportedly Probing Altria's $12.8 Billion Stake in E-Cigarette Maker JUUL
The federal agency is concerned that the tobacco giant failed to adequately disclose the risk it was taking with investing in JUUL.
Want to Get Rich Investing in Healthcare? Check Out These Diabetes Stocks
The worst performer among these stocks has soared more than 70% over the last 12 months.
Here's How eHealth Trounced Expectations in Q4
The provider of an online health insurance exchange blew past Wall Street revenue and earnings estimates.
How Community Health Systems Hit a Home Run in Q4
The hospital operator easily beat Wall Street revenue and earnings expectations with its Q4 results.
Why Community Health Systems Stock Is Crushing It Today
The hospital operator handily beat expectations with its Q4 results.
3 Marijuana Stocks That Rode Canopy Growth's Q3 Earnings Coattails and Could Rise Even Higher
Two of these Canadian pot stocks could have especially bright prospects.
How Masimo Blew Past Wall Street Estimates in Q4
Demand continued to be strong for the medical technology company's pulse oximetry devices.
Why Invitae's Q4 Results Failed to Wow Investors
This high-flying stock's momentum could falter after missing Wall Street's revenue expectations.
Why Senseonics Holdings Shares Jumped Today
Investors reacted enthusiastically to a positive coverage decision for the company's Eversense CGM device.
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
The animal-health company posted lower-than-expected revenue in Q4.
What's Behind Bausch Health's Disappointing Q4 Earnings Results
The healthcare company narrowly topped revenue expectations in Q4 but failed to meet Wall Street's earnings estimate.
Is Aurora Cannabis a Hunk of Junk or a Dumpster Diver's Dream?
Some think the beaten-down marijuana stock is a lost cause. Others think it could make a major comeback.